世界のパーキンソン病市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Parkinson's Disease Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4438 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、パーキンソン病のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（カルビドパ/レボドパ、ドーパミン受容体作動薬、MAO阻害薬）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・パーキンソン病の市場動向 ・企業の競争状況、市場シェア ・パーキンソン病の種類別市場規模（カルビドパ/レボドパ、ドーパミン受容体作動薬、MAO阻害薬） ・パーキンソン病の用途別市場規模（病院、診療所） ・パーキンソン病の北米市場規模2016-2027（アメリカ、カナダ） ・パーキンソン病のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・パーキンソン病のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・パーキンソン病の中南米市場規模2016-2027（メキシコ、ブラジル） ・パーキンソン病の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Teva、Novartis、GSK、AbbVie、Merck、Boehringer Ingelheim、Amneal + Impax、Lundbeck、Sun Pharma、Wockhardt、UCB、Bausch Health、Acadia） ・結論

Market Analysis and Insights: Global Parkinson’s Disease Market
The global Parkinson’s Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Parkinson’s Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Parkinson’s Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Parkinson’s Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Parkinson’s Disease market.

Global Parkinson’s Disease Scope and Market Size
Parkinson’s Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson’s Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors

Segment by Application
Hospitals
Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Teva
Novartis
GSK
AbbVie
Merck
Boehringer Ingelheim
Amneal + Impax
Lundbeck
Sun Pharma
AbbVie
Merck

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson’s Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Carbidopa/Levodopa
1.2.3 Dopamine Receptor Agonists
1.2.4 MAO-Inhibitors
1.3 Market by Application
1.3.1 Global Parkinson’s Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Parkinson’s Disease Market Perspective (2016-2027)
2.2 Parkinson’s Disease Growth Trends by Regions
2.2.1 Parkinson’s Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Parkinson’s Disease Historic Market Share by Regions (2016-2021)
2.2.3 Parkinson’s Disease Forecasted Market Size by Regions (2022-2027)
2.3 Parkinson’s Disease Industry Dynamic
2.3.1 Parkinson’s Disease Market Trends
2.3.2 Parkinson’s Disease Market Drivers
2.3.3 Parkinson’s Disease Market Challenges
2.3.4 Parkinson’s Disease Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Parkinson’s Disease Players by Revenue
3.1.1 Global Top Parkinson’s Disease Players by Revenue (2016-2021)
3.1.2 Global Parkinson’s Disease Revenue Market Share by Players (2016-2021)
3.2 Global Parkinson’s Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Parkinson’s Disease Revenue
3.4 Global Parkinson’s Disease Market Concentration Ratio
3.4.1 Global Parkinson’s Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Revenue in 2020
3.5 Parkinson’s Disease Key Players Head office and Area Served
3.6 Key Players Parkinson’s Disease Product Solution and Service
3.7 Date of Enter into Parkinson’s Disease Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Parkinson’s Disease Breakdown Data by Type
4.1 Global Parkinson’s Disease Historic Market Size by Type (2016-2021)
4.2 Global Parkinson’s Disease Forecasted Market Size by Type (2022-2027)

5 Parkinson’s Disease Breakdown Data by Application
5.1 Global Parkinson’s Disease Historic Market Size by Application (2016-2021)
5.2 Global Parkinson’s Disease Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Parkinson’s Disease Market Size (2016-2027)
6.2 North America Parkinson’s Disease Market Size by Type
6.2.1 North America Parkinson’s Disease Market Size by Type (2016-2021)
6.2.2 North America Parkinson’s Disease Market Size by Type (2022-2027)
6.2.3 North America Parkinson’s Disease Market Size by Type (2016-2027)
6.3 North America Parkinson’s Disease Market Size by Application
6.3.1 North America Parkinson’s Disease Market Size by Application (2016-2021)
6.3.2 North America Parkinson’s Disease Market Size by Application (2022-2027)
6.3.3 North America Parkinson’s Disease Market Size by Application (2016-2027)
6.4 North America Parkinson’s Disease Market Size by Country
6.4.1 North America Parkinson’s Disease Market Size by Country (2016-2021)
6.4.2 North America Parkinson’s Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Parkinson’s Disease Market Size (2016-2027)
7.2 Europe Parkinson’s Disease Market Size by Type
7.2.1 Europe Parkinson’s Disease Market Size by Type (2016-2021)
7.2.2 Europe Parkinson’s Disease Market Size by Type (2022-2027)
7.2.3 Europe Parkinson’s Disease Market Size by Type (2016-2027)
7.3 Europe Parkinson’s Disease Market Size by Application
7.3.1 Europe Parkinson’s Disease Market Size by Application (2016-2021)
7.3.2 Europe Parkinson’s Disease Market Size by Application (2022-2027)
7.3.3 Europe Parkinson’s Disease Market Size by Application (2016-2027)
7.4 Europe Parkinson’s Disease Market Size by Country
7.4.1 Europe Parkinson’s Disease Market Size by Country (2016-2021)
7.4.2 Europe Parkinson’s Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Parkinson’s Disease Market Size (2016-2027)
8.2 Asia-Pacific Parkinson’s Disease Market Size by Type
8.2.1 Asia-Pacific Parkinson’s Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Parkinson’s Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Parkinson’s Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Parkinson’s Disease Market Size by Application
8.3.1 Asia-Pacific Parkinson’s Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Parkinson’s Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Parkinson’s Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Parkinson’s Disease Market Size by Region
8.4.1 Asia-Pacific Parkinson’s Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Parkinson’s Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Parkinson’s Disease Market Size (2016-2027)
9.2 Latin America Parkinson’s Disease Market Size by Type
9.2.1 Latin America Parkinson’s Disease Market Size by Type (2016-2021)
9.2.2 Latin America Parkinson’s Disease Market Size by Type (2022-2027)
9.2.3 Latin America Parkinson’s Disease Market Size by Type (2016-2027)
9.3 Latin America Parkinson’s Disease Market Size by Application
9.3.1 Latin America Parkinson’s Disease Market Size by Application (2016-2021)
9.3.2 Latin America Parkinson’s Disease Market Size by Application (2022-2027)
9.3.3 Latin America Parkinson’s Disease Market Size by Application (2016-2027)
9.4 Latin America Parkinson’s Disease Market Size by Country
9.4.1 Latin America Parkinson’s Disease Market Size by Country (2016-2021)
9.4.2 Latin America Parkinson’s Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Parkinson’s Disease Market Size (2016-2027)
10.2 Middle East & Africa Parkinson’s Disease Market Size by Type
10.2.1 Middle East & Africa Parkinson’s Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Parkinson’s Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Parkinson’s Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Parkinson’s Disease Market Size by Application
10.3.1 Middle East & Africa Parkinson’s Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Parkinson’s Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Parkinson’s Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Parkinson’s Disease Market Size by Country
10.4.1 Middle East & Africa Parkinson’s Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Parkinson’s Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Parkinson’s Disease Introduction
11.1.4 Teva Revenue in Parkinson’s Disease Business (2016-2021)
11.1.5 Teva Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Parkinson’s Disease Introduction
11.2.4 Novartis Revenue in Parkinson’s Disease Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson’s Disease Introduction
11.3.4 GSK Revenue in Parkinson’s Disease Business (2016-2021)
11.3.5 GSK Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Parkinson’s Disease Introduction
11.4.4 AbbVie Revenue in Parkinson’s Disease Business (2016-2021)
11.4.5 AbbVie Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Parkinson’s Disease Introduction
11.5.4 Merck Revenue in Parkinson’s Disease Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Parkinson’s Disease Introduction
11.6.4 Boehringer Ingelheim Revenue in Parkinson’s Disease Business (2016-2021)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Amneal + Impax
11.7.1 Amneal + Impax Company Details
11.7.2 Amneal + Impax Business Overview
11.7.3 Amneal + Impax Parkinson’s Disease Introduction
11.7.4 Amneal + Impax Revenue in Parkinson’s Disease Business (2016-2021)
11.7.5 Amneal + Impax Recent Development
11.8 Lundbeck
11.8.1 Lundbeck Company Details
11.8.2 Lundbeck Business Overview
11.8.3 Lundbeck Parkinson’s Disease Introduction
11.8.4 Lundbeck Revenue in Parkinson’s Disease Business (2016-2021)
11.8.5 Lundbeck Recent Development
11.9 Sun Pharma
11.9.1 Sun Pharma Company Details
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma Parkinson’s Disease Introduction
11.9.4 Sun Pharma Revenue in Parkinson’s Disease Business (2016-2021)
11.9.5 Sun Pharma Recent Development
11.10 Wockhardt
11.10.1 Wockhardt Company Details
11.10.2 Wockhardt Business Overview
11.10.3 Wockhardt Parkinson’s Disease Introduction
11.10.4 Wockhardt Revenue in Parkinson’s Disease Business (2016-2021)
11.10.5 Wockhardt Recent Development
11.11 UCB
11.11.1 UCB Company Details
11.11.2 UCB Business Overview
11.11.3 UCB Parkinson’s Disease Introduction
11.11.4 UCB Revenue in Parkinson’s Disease Business (2016-2021)
11.11.5 UCB Recent Development
11.12 Bausch Health
11.12.1 Bausch Health Company Details
11.12.2 Bausch Health Business Overview
11.12.3 Bausch Health Parkinson’s Disease Introduction
11.12.4 Bausch Health Revenue in Parkinson’s Disease Business (2016-2021)
11.12.5 Bausch Health Recent Development
11.13 Acadia
11.13.1 Acadia Company Details
11.13.2 Acadia Business Overview
11.13.3 Acadia Parkinson’s Disease Introduction
11.13.4 Acadia Revenue in Parkinson’s Disease Business (2016-2021)
11.13.5 Acadia Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Parkinson's Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Carbidopa/Levodopa
Table 3. Key Players of Dopamine Receptor Agonists
Table 4. Key Players of MAO-Inhibitors
Table 5. Global Parkinson's Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Parkinson's Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Parkinson's Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Parkinson's Disease Market Share by Regions (2016-2021)
Table 9. Global Parkinson's Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Parkinson's Disease Market Share by Regions (2022-2027)
Table 11. Parkinson's Disease Market Trends
Table 12. Parkinson's Disease Market Drivers
Table 13. Parkinson's Disease Market Challenges
Table 14. Parkinson's Disease Market Restraints
Table 15. Global Parkinson's Disease Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Parkinson's Disease Market Share by Players (2016-2021)
Table 17. Global Top Parkinson's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease as of 2020)
Table 18. Ranking of Global Top Parkinson's Disease Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Parkinson's Disease Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Parkinson's Disease Product Solution and Service
Table 22. Date of Enter into Parkinson's Disease Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Parkinson's Disease Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Parkinson's Disease Revenue Market Share by Type (2016-2021)
Table 26. Global Parkinson's Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Parkinson's Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Parkinson's Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Parkinson's Disease Revenue Market Share by Application (2016-2021)
Table 30. Global Parkinson's Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Parkinson's Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Parkinson's Disease Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Parkinson's Disease Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Parkinson's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Parkinson's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Parkinson's Disease Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Parkinson's Disease Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Parkinson's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Parkinson's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Parkinson's Disease Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Parkinson's Disease Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Parkinson's Disease Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Parkinson's Disease Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Parkinson's Disease Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Parkinson's Disease Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Parkinson's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Parkinson's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Parkinson's Disease Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Parkinson's Disease Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Parkinson's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Parkinson's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 62. Teva Company Details
Table 63. Teva Business Overview
Table 64. Teva Parkinson's Disease Product
Table 65. Teva Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 66. Teva Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Parkinson's Disease Product
Table 70. Novartis Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. GSK Company Details
Table 73. GSK Business Overview
Table 74. GSK Parkinson's Disease Product
Table 75. GSK Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 76. GSK Recent Development
Table 77. AbbVie Company Details
Table 78. AbbVie Business Overview
Table 79. AbbVie Parkinson's Disease Product
Table 80. AbbVie Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 81. AbbVie Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Parkinson's Disease Product
Table 85. Merck Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Boehringer Ingelheim Company Details
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Parkinson's Disease Product
Table 90. Boehringer Ingelheim Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 91. Boehringer Ingelheim Recent Development
Table 92. Amneal + Impax Company Details
Table 93. Amneal + Impax Business Overview
Table 94. Amneal + Impax Parkinson's Disease Product
Table 95. Amneal + Impax Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 96. Amneal + Impax Recent Development
Table 97. Lundbeck Company Details
Table 98. Lundbeck Business Overview
Table 99. Lundbeck Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 100. Lundbeck Recent Development
Table 101. Sun Pharma Company Details
Table 102. Sun Pharma Business Overview
Table 103. Sun Pharma Parkinson's Disease Product
Table 104. Sun Pharma Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 105. Sun Pharma Recent Development
Table 106. Wockhardt Company Details
Table 107. Wockhardt Business Overview
Table 108. Wockhardt Parkinson's Disease Product
Table 109. Wockhardt Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 110. Wockhardt Recent Development
Table 111. UCB Company Details
Table 112. UCB Business Overview
Table 113. UCB Parkinson's Disease Product
Table 114. UCB Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 115. UCB Recent Development
Table 116. Bausch Health Company Details
Table 117. Bausch Health Business Overview
Table 118. Bausch Health Parkinson's Disease Product
Table 119. Bausch Health Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 120. Bausch Health Recent Development
Table 121. Acadia Company Details
Table 122. Acadia Business Overview
Table 123. Acadia Parkinson's Disease Product
Table 124. Acadia Revenue in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 125. Acadia Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson's Disease Market Share by Type: 2020 VS 2027
Figure 2. Carbidopa/Levodopa Features
Figure 3. Dopamine Receptor Agonists Features
Figure 4. MAO-Inhibitors Features
Figure 5. Global Parkinson's Disease Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Parkinson's Disease Report Years Considered
Figure 9. Global Parkinson's Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Parkinson's Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Parkinson's Disease Market Share by Regions: 2020 VS 2027
Figure 12. Global Parkinson's Disease Market Share by Regions (2022-2027)
Figure 13. Global Parkinson's Disease Market Share by Players in 2020
Figure 14. Global Top Parkinson's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Parkinson's Disease Revenue in 2020
Figure 16. Global Parkinson's Disease Revenue Market Share by Type (2016-2021)
Figure 17. Global Parkinson's Disease Revenue Market Share by Type (2022-2027)
Figure 18. North America Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Parkinson's Disease Market Share by Type (2016-2027)
Figure 20. North America Parkinson's Disease Market Share by Application (2016-2027)
Figure 21. North America Parkinson's Disease Market Share by Country (2016-2027)
Figure 22. United States Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Parkinson's Disease Market Share by Type (2016-2027)
Figure 26. Europe Parkinson's Disease Market Share by Application (2016-2027)
Figure 27. Europe Parkinson's Disease Market Share by Country (2016-2027)
Figure 28. Germany Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Parkinson's Disease Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Parkinson's Disease Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Parkinson's Disease Market Share by Region (2016-2027)
Figure 38. China Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Parkinson's Disease Market Share by Type (2016-2027)
Figure 46. Latin America Parkinson's Disease Market Share by Application (2016-2027)
Figure 47. Latin America Parkinson's Disease Market Share by Country (2016-2027)
Figure 48. Mexico Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Parkinson's Disease Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Parkinson's Disease Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Parkinson's Disease Market Share by Country (2016-2027)
Figure 54. Turkey Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Teva Revenue Growth Rate in Parkinson's Disease Business (2016-2021)
Figure 58. Novartis Revenue Growth Rate in Parkinson's Disease Business (2016-2021)
Figure 59. GSK Revenue Growth Rate in Parkinson's Disease Business (2016-2021)
Figure 60. AbbVie Revenue Growth Rate in Parkinson's Disease Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Parkinson's Disease Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Business (2016-2021)
Figure 63. Amneal + Impax Revenue Growth Rate in Parkinson's Disease Business (2016-2021)
Figure 64. Lundbeck Revenue Growth Rate in Parkinson's Disease Business (2016-2021)
Figure 65. Sun Pharma Revenue Growth Rate in Parkinson's Disease Business (2016-2021)
Figure 66. Wockhardt Revenue Growth Rate in Parkinson's Disease Business (2016-2021)
Figure 67. UCB Revenue Growth Rate in Parkinson's Disease Business (2016-2021)
Figure 68. Bausch Health Revenue Growth Rate in Parkinson's Disease Business (2016-2021)
Figure 69. Acadia Revenue Growth Rate in Parkinson's Disease Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---